Kornberg Roger D. 4
4 · Cocrystal Pharma, Inc. · Filed Jul 20, 2023
Insider Transaction Report
Form 4
Kornberg Roger D.
Director
Transactions
- Award
Stock Options (Right to Buy)
2023-07-18+24,417→ 24,417 totalExercise: $2.67Exp: 2033-07-18→ Common Stock (24,417 underlying)
Footnotes (1)
- [F1]The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 18, 2024 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2024, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date.